$1.87
0.084.47%
Pre-Market: 4:21 PM EDT
Comments
Loading...
Moleculin Biotech (NASDAQ:MBRX) Stock, Earnings Estimates, EPS, And Revenue
Moleculin Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 8
EPS
$-2.850
Quarterly Revenue
$0
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Moleculin Biotech using advanced sorting and filters.
Data brought to you by Benzinga APIs
Moleculin Biotech (MBRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-08 | $-2.85 | $-2.44 | -16.8 % |
| Jun 2024 | 2024-08-14 | $-1.70 | $-2.31 | 26.4 % |
| Mar 2024 | 2024-05-10 | $-2.02 | $-3.53 | 42.8 % |
| Dec 2023 | 2024-03-22 | $-5.09 | $-3.05 | -66.9 % |
Moleculin Biotech (MBRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?
Moleculin Biotech (MBRX) is scheduled to report earnings on March 21, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
What were the latest earnings per share (EPS) for Moleculin Biotech (NASDAQ:MBRX)?
The Actual EPS was $-2.85, which missed the estimate of $-2.44.
What were Moleculin Biotech’s (NASDAQ:MBRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.